Karamedica
Pre-clinicalKaramedica wants to expand medical uses of biopolymer-based products, especially containing chitosan, by developing novel decontamination processes.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Karamedica wants to expand medical uses of biopolymer-based products, especially containing chitosan, by developing novel decontamination processes.
Medical DevicesDigital Health